Thursday, January 1, 2026 1/1/2026

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients

Award Number: R21CA244078
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2020
PERIOD OF PERFORMANCE END DATE: 07/31/2025

Group Awards By:

View Award Description

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients - PROJECT ABSTRACT The risk for anal cancer in HIV-positive individuals is up to 80-times higher than the general population with the incidence among HIV-positive men ranging between 49-131/100,000 person-years which is higher than the incidence of cervical cancer prior to universal screening with cervical cytology. Even though anal cancer prevention can be achieved with human papillomavirus vaccination, those who are currently at highest risk for anal cancer have already been exposed to HPV and remain at high risk for anal dysplasia/cancer. Thus, identifying best-practices for anal cancer prevention through anal dysplasia screening in HIV-positive individuals would be beneficial. However, acceptance of anal cytology as the gold standard for screening has not been universally recognized due to issues related to cost-effectiveness, reliability and accuracy. Current guidelines recommend high resolution anoscopy (HRA)-guided biopsies as a follow-up to abnormal anal cytologies although HRA is invasive with potential downsides including patient discomfort and anxiety associated with biopsies. Therefore, identifying less-invasive screening paradigms could revolutionize anal cancer screening programs in this vulnerable population. The project will adapt a novel technology, Raman- enhanced spectroscopy (RESpect), which is a laser-based tool that characterizes chemical molecular composition of cells and tissue. The study builds upon preliminary data which demonstrated unique RESpect fingerprints of anal dysplastic tissues from normal to low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL). Because standard RESpect protocol requires HRA-guided biopsies to obtain anal tissue to identify RESpect signatures in the laboratory, an innovative approach will adapt a novel portable fiber-optic RESpect probe to assess real-time screening and diagnosis. The central hypotheses are: 1) RESpect fingerprints will characterize a spectrum of anal dysplasia/cancer in HIV-positive individuals; and 2) RESpect fingerprints obtained by a portable probe are comparable to standard RESpect signatures obtained by the RESpect instrument. The novel proposal will translate RESpect technology to anal histologies from screening/diagnosis to potential clinical translational applications. The significance of the study lies in contributing new knowledge and identifying novel RESpect fingerprints as biomarkers in HIV-associated anal dysplasia/cancer which synergizes knowledge with technology to improve screening to improve healthcare delivery.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$58 )
2026	2020	UNIVERSITY OF HAWAII	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cancer Detection and Diagnosis Research	000	1	10/1/2025	NEW	-$58
														Subtotal = -$58

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2020	UNIVERSITY OF HAWAII	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cancer Detection and Diagnosis Research	000	1	1/8/2025	NEW	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2020	UNIVERSITY OF HAWAII	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cancer Detection and Diagnosis Research	000	1	9/19/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2020	UNIVERSITY OF HAWAII	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cancer Detection and Diagnosis Research	000	1	8/17/2023	NEW	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2020	UNIVERSITY OF HAWAII SYSTEMS	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cancer Detection and Diagnosis Research	000	1	11/18/2020	NEW	$0
														Subtotal = $0

Issue Date FY: 2020 ( Subtotal = $400,414 )
2020	2020	UNIVERSITY OF HAWAII SYSTEMS	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cancer Detection and Diagnosis Research	000	1	7/24/2020	NEW	$400,414
														Subtotal = $400,414

Grand Total All Awards = $400,356

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients

Award Number: R21CA244078

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2020

PERIOD OF PERFORMANCE END DATE: 07/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer